Rocket


News + Filings
Transactions
Holdings


All
13F
13D/G
Other

BLATT LAWRENCE Create: Alert

All | News | Filings
Date FiledTypeDescription
03/17/2023 4 BLATT LAWRENCE (CEO) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns: Granted 242,500 options to buy @ $1.34, valued at $325k
02/08/2023 SC 13G/A BLATT LAWRENCE reports a 6.5% stake in Aligos Therapeutics, Inc.
07/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2022 SC 13G/A BLATT LAWRENCE reports a 6.2% stake in Aligos Therapeutics, Inc.
02/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/11/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/03/2020 4 BLATT LAWRENCE (CEO) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns: Granted 450,000 options to buy @ $16.18, valued at $7.3M
10/20/2020 4 BLATT LAWRENCE (CEO) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns: Converted 41,016 shares @ $0
Converted 122,601 shares @ $0
Converted 13,671 shares @ $0
Converted 13,671 shares @ $0
Converted 50,712 shares @ $0
Converted 3,394 shares @ $0
Converted 3,394 shares @ $0
Converted 21,695 shares @ $0
Converted 1,452 shares @ $0
Converted 1,452 shares @ $0
Converted 41,016 preferred shares @ $0
10/15/2020 3 BLATT LAWRENCE (CEO) has filed a Form 3 on Aligos Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy